Hansen Medical (HNSN) Reports Q3 Loss of $0.54; Announces Cost Reduction Program

Hansen Medical (NASDAQ: HNSN) reported Q3 EPS of ($0.54), versus ($1.30) reported last year. Revenue for the quarter came in at $3.18 million, versus $3.88 million reported last year.

The Company today announces a broad cost reduction program, which when fully implemented, is expected to further reduce the break-even point of the company to approximately $40 million in annual revenue, improve cash flow and allow for further investment in new technology and new markets. The cost reduction programs include the reduction of non-R&D related headcount, continued reduction of third party services and a more capital efficient facility location.

For earnings history and earnings-related data on Hansen Medical (HNSN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49